Finally, studies of men with advanced PC whose PSA levels were much higher than those of men with early-stage disease would not suffer from such a detection bias because their PSA levels at diagnosis would still meet the biopsy criteria even though their use of NSAIDs may result in a modest reduction in PSA levels (31). This evidence concerns the gene KLK3 and pachyonychia congenita.